These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Differential Protein Expression in Congenital and Acquired Cholesteatomas. Shin SH; Huang M; Kim SH; Choi JY PLoS One; 2015; 10(9):e0137011. PubMed ID: 26335306 [TBL] [Abstract][Full Text] [Related]
11. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected? Ayache S; Tramier B; Strunski V Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388 [TBL] [Abstract][Full Text] [Related]
13. [Congenital cholesteatomas in Japanese--forty from our experience and fifty-five from a survey of the Japanese literature]. Suetake M; Kobayashi T; Sasaki N; Takasaka T; Yuasa R Nihon Jibiinkoka Gakkai Kaiho; 1996 Sep; 99(9):1200-7. PubMed ID: 8914417 [TBL] [Abstract][Full Text] [Related]
14. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595 [TBL] [Abstract][Full Text] [Related]
15. Alteration in cholesteatoma fibroblasts: induction of neoplastic-like phenotype. Parisier SC; Agresti CJ; Schwartz GK; Han JC; Albino AP Am J Otol; 1993 Mar; 14(2):126-30. PubMed ID: 8503484 [TBL] [Abstract][Full Text] [Related]
16. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications. Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944 [TBL] [Abstract][Full Text] [Related]
17. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas. Juhász A; Sziklai I; Rákosy Z; Ecsedi S; Adány R; Balázs M Otol Neurotol; 2009 Jun; 30(4):559-65. PubMed ID: 19395987 [TBL] [Abstract][Full Text] [Related]
18. Reversible canal wall down mastoidectomy for acquired cholesteatomas: preliminary results. McElveen JT; Chung AT Laryngoscope; 2003 Jun; 113(6):1027-33. PubMed ID: 12782816 [TBL] [Abstract][Full Text] [Related]
19. [Comparative analysis of the proliferative capacity of cholesteatomas]. Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952 [TBL] [Abstract][Full Text] [Related]
20. [DNA cytometric studies of cholesteatoma of the middle ear]. Bollmann R; Knopp U; Tolsdorff P HNO; 1991 Aug; 39(8):313-4. PubMed ID: 1938497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]